Thomas Lennart Eklund

Président chez SWEDENCARE AB Fortune : 6 M $ au 31/05/2026

Profil

Mr. Thomas Lennart Eklund is an Independent Director at Surgical Science Sweden AB, an Industrial Partner at Impilo AB, a Chairman at Swedencare AB, an Independent Director at Boule Diagnostics AB, a Chairman at Circassia AB, a Chairman at Itrim Sverige AB, a Chairman at Mabtech Group Holding AB, a Chairman at Mabtech Holding AB, a Chairman at Sedana Medical AG, a Chief Executive Officer & Director at Tedsalus AB, an Investment Director at Alfred Berg ABN AMRO Capital Investment AB and a Vice President at Handelsbanken Markets Norge.
He is on the Board of Directors at Devyser Diagnostics AB, Surgical Science Sweden AB, Boule Diagnostics AB, Tedsalus AB, Bariatric & Diabetes Center Ajman AB, Bio-Works Sweden AB, Bioworks AB, Devyser AB, Excillum AB, GHP International AB, Immedica Pharma Holding AB, Impilo No 4 Holding Ii AB, Memira Holding AB, Rodebjer Form AB and Tedcap AB. Mr. Eklund was previously employed as a Chairman by Immedica Pharma AB, a Chairman by Mabtech AB, an Independent Director by Bio-Works Technologies AB, an Independent Director by SciBase Holding AB, a Chairman by Moberg Pharma AB, a Chairman by Sedana Medical AB, an Independent Director by Aerocrine AB, a Chairman by GHP Specialty Care AB, a Managing Director by Investor Growth Capital AB, a Chairman by BoMill AB, a Chairman by Bomill Holding AB, a Chief Executive Officer by Investor Growth Capital AB, a Chairman by Itrim Holding AB, a Deputy Director by Newron Sweden AB, a Deputy Director by SciBase AB, a Deputy Director by Scibase Intressenter AB, a Chairman by Swevet Holding AB, a Chairman by Swevet Piab AB, and a Chairman by Termino C 10180 AB. He received his MBA from Stockholm School of Economics.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
SWEDENCARE AB 0,63 %	16/02/2026	1 009 060 ( 0,63 % )	3 M $	31/05/2026
SEDANA MEDICAL AB 1,68 %	31/12/2024	1 666 464 ( 1,68 % )	2 M $	31/05/2026
SURGICAL SCIENCE SWEDEN AB 0,78 %	28/11/2025	399 170 ( 0,78 % )	2 M $	31/05/2026

Postes actifs de Thomas Lennart Eklund

Sociétés	Poste	Début
BOULE DIAGNOSTICS AB	Directeur/Membre du Conseil	01/01/2014
SWEDENCARE AB	Président	01/01/2026
SURGICAL SCIENCE SWEDEN AB	Directeur/Membre du Conseil	01/01/2017
DEVYSER DIAGNOSTICS AB	Directeur/Membre du Conseil	01/01/2024
GHP International AB	Directeur/Membre du Conseil	-
Handelsbanken Markets Norge	Corporate Officer/Principal	-
Tedsalus AB	Directeur Général	-
Excillum AB	Directeur/Membre du Conseil	-
Circassia AB	Président	-
░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░ ░░ ░ ░░░░░░░ ░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-

Anciens postes connus de Thomas Lennart Eklund

Sociétés	Poste	Fin
░░░░░░░ ░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░ ░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░